1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUPHORIA THERAPEUTICS INC.
Neuphoria Therapeutics Inc. XNAS: NEUP

Neuphoria Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

about

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral...

Read More
8.56 -0.13 (-1.50%)
31.79% Fall from 52W High
42,107
XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Mid Valuation
43.7 / 100
Momentum Score
Technically Bullish
73.7 / 100
Analyst Price Target
No estimates available

17

S

4

W

0

O

2

T

SWOT Analysis

Neuphoria Therapeutics Inc. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..